Gene deletions in complement factor H related protein gene locus and kidney transplantation

Markkinen Salla,Inkeri Lokki,Helanterä Ilkka,Ritari Jarmo,Partanen Jukka,Meri Seppo,Hyvärinen Kati

DOI: https://doi.org/10.1101/2024.02.18.24301068

2024-02-19

Abstract:We recently reported that a homozygous deletion in the complement factor H related ( ) protein gene locus predisposed kidney transplant patients to allograft rejection. As donors carried normal functional genes in the locus, the susceptibility may have resulted from alloimmune reaction to CFHR proteins. However, we found no evidence for anti-CFH response in the patients. It is therefore possible that the gene deletions and consequent protein deficiencies as such affect the rejection risk. Using multiplex ligation-dependent probe amplification method and genome sequencing, we confirmed that all 15 patients homozygous for rs7542235 GG, a SNP tagging the CFHR311 deletion had deletions of various sizes that invariably encompassed the whole of gene. The lack of CFHR1 protein in patient plasma samples was also demonstrated by Western blotting. Plasma proteomics analyses of biobank samples demonstrated that rs7542235 allele G associates with significantly changed expression levels of 23 proteins (FDR <0.010). These proteins are involved in various pathways, including regulation of alloimmune response and their roles in transplantation outcome merit further studies. Although gene abnormalities have been associated with kidney diseases, we observed no clinical characteristics shared by or enriched in patients homozygous for deletion. This suggests that the deletion as such was not enriched in a baseline disease in this subgroup with a high risk for rejection. To conclude, the different deletion types found in patients shared the complete deletion of the gene pointing to its primary role. Plasma proteomics studies show that deletion-tagging allele is associated with altered expression of CFH/CFHR proteins.

Genetic and Genomic Medicine